Literature DB >> 15519511

Surgery and outcomes of ductal carcinoma in situ of the breast: a population-based study in Australia.

Anne Kricker1, Bruce Armstrong.   

Abstract

We examined surgery and outcome in a population-based series of 2109 women newly diagnosed with ductal carcinoma in situ (DCIS) in 1995-2000 in New South Wales (NSW), Australia. The sole data source for the study was pathology records in the NSW Cancer Registry. Most DCIS was treated with breast-conserving surgery (BCS); use of breast conservation increased throughout the 6 years of the study. Women who were younger, had higher grade DCIS or had larger lesions were significantly and independently less likely to have BCS than other women. Eighteen percent of women had lymph nodes removed, most often with mastectomy. The NSW Cancer Registry does not collect information about radiotherapy. Based on cancer registrations alone, 97.7% of women were free of ipsilateral invasive cancer after three years; more women who had mastectomy were cancer-free (100%) than women who had breast-conserving surgery (97.2%; P=0.05).

Entities:  

Mesh:

Year:  2004        PMID: 15519511     DOI: 10.1016/j.ejca.2004.07.008

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

1.  International variation in management of screen-detected ductal carcinoma in situ of the breast.

Authors:  Antonio Ponti; Elsebeth Lynge; Ted James; Ondřej Májek; My von Euler-Chelpin; Ahti Anttila; Patricia Fitzpatrick; Maria Piera Mano; Masaaki Kawai; Astrid Scharpantgen; Jacques Fracheboud; Solveig Hofvind; Carmen Vidal; Nieves Ascunce; Dolores Salas; Jean-Luc Bulliard; Nereo Segnan; Karla Kerlikowske; Stephen Taplin
Journal:  Eur J Cancer       Date:  2014-08-19       Impact factor: 9.162

2.  Clinical experience of patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery plus radiotherapy: a preliminary report.

Authors:  Ji-Young Jang; Mi-Ryeong Ryu; Sung-Whan Kim; Chul-Seung Kay; Yeon-Sil Kim; Yoon-Kyeong Oh; Hyung-Chul Kwon; Sei-Chul Yoon; Woo-Chan Park; Byung-Joo Song; Se-Jeong Oh; Sang-Seol Jung; Jong-Man Won; Seung-Nam Kim; Su-Mi Chung
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

3.  No excess mortality in patients aged 50 years and older who received treatment for ductal carcinoma in situ of the breast.

Authors:  Esther Bastiaannet; Willemien van de Water; Rudi G J Westendorp; Maryska L G Janssen-Heijnen; Cornelis J H van de Velde; Anton J M de Craen; Gerrit-Jan Liefers
Journal:  Int J Surg Oncol       Date:  2012-05-13

4.  Influence of electrical and thermal properties on RF ablation of breast cancer: is the tumour preferentially heated?

Authors:  Vilhelm Ekstrand; Hans Wiksell; Inkeri Schultz; Bengt Sandstedt; Samuel Rotstein; Anders Eriksson
Journal:  Biomed Eng Online       Date:  2005-07-11       Impact factor: 2.819

5.  Compliance with guidelines is related to better local recurrence-free survival in ductal carcinoma in situ.

Authors:  M A J de Roos; G H de Bock; P C Baas; L de Munck; T Wiggers; J de Vries
Journal:  Br J Cancer       Date:  2005-11-14       Impact factor: 7.640

Review 6.  Current view on ductal carcinoma in situ and importance of the margin thresholds: A review.

Authors:  A Van Cleef; S Altintas; M Huizing; K Papadimitriou; P Van Dam; W Tjalma
Journal:  Facts Views Vis Obgyn       Date:  2014
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.